2001

21. Adachi Y, Reynolds PN, Yamamoto M (P4) , Minghui W, Takayama K, Matsubara S, Muramatsu T, Curiel DT (P4) : Midkine promoter-based conditionally replicative adenovirus for the treatment of pediatric solid tumors and bone marrow tumor purging. Cancer Res 1:7882-7888, 2001.

22. Alemany R, Curiel DT (P4) : CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Therapy 8:1347-1352, 2001.

23. Balague C, Noya F, Alemany R, Chow LT, Curiel DT (P4) : Human papillomavirus E6E7-mediated cytolysis by an adenovirus mutant: Selective replication ascertained in organotypic cultures of human keratinocytes. J Virol 75:7602-7611, 2001.

24. Barker SD, Casado E, Gomez-Navarro J, Xiang J, Arafat W, Mahasreshti P, Pustilnik TB, Hemminki A (CD) , Siegal GP (CB) , Alvarez RD, Curiel DT (P4) : An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites. Gyn Onc 82:57-63, 2001.

25. Beenken SW (CA, P1) , Grizzle WE (CC) , Crowe DR, Conner MG, Weiss HL, Sellers MT, Krontiras H (P3, PP, CD) , Urist MM, Bland KI (CA) : Molecular biomarkers for breast cancer prognosis: Co-expression of c-erbB-2 in p53. Annals of Surgery 233:630-638, 2001.

26. Beenken SW (CA, P1) , Urist MM, Bland KI (CA) : Breast cancer: Cellular biochemical and molecular biomarkers. In: Cameron JL (ed), Current Surgical Therapy, 7th Edition. Mosby, Inc., St. Louis , MO , pp. 697-701, 2001.

27. Casado E, Gomez-Navarro J, Yamamoto M (P4) , Adachi Y, Coolidge CJ, Arafat WO, Barker S, Wang MH, Mahasreshi PJ, Hemminki A (CD) , Gonzalez-Baron M, Barnes MN, Siegal GP (CB) , Alvarez RD, Curiel DT (P4) : Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications. Clin Cancer Res 7:2496-2504, 2001.

28. Casado E, Nettelbeck DM, Gomez-Navarro J, Hemminki A (CD) , Gonzalez-Baron M, Siegal GP (CB) , Barnes MN , Alvarez RD , Curiel DT (P4) : Transcriptional targeting for ovarian cancer gene therapy: A review. Gynecol Oncol 82:229-237, 2001.

29. Chaudhuri TR, Mountz JM, Rogers BE, Partridge EE, Zinn KR (CD) : Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy. Gyn Oncol 82:581-589, 2001.

30. Chung MA, Bland KI (CA) : Principles of Oncology. In: Williamson CJ (ed), Surgery. Harcourt, January 2001.

31. Covington C, Mitchell-Gieleghem A, Lawson D, Eto I, Grubbs CJ (P1) : Presence of carotenoid, an anticarcinogenic marker in nipple aspirates postlactation. Adv Exp Med Biol 501:143-152, 2001.

32. Dawson MI, Park JH, Chao WR, Dousman L, Waleh N, Hobbs PD, Jong L, Toll LR, Zhang XK, Chen GQ, Gu J, Merchant JL, Bai L, Verma AK, Thacher SM, Chandraratna RAS, Shroot B, Hill DL (P1) : Retinoic acid receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by retinoids: A potential role for trans-RA-induced ZBP-89 in ODC inhibition. Int J Cancer 91:8-21, 2001.

33. Devedijev Y, Symersky J, Sing R, Jedrzejas MJ, Brouillette CG, Brouillette WJ (P1) , Muccio DD (P1) , Chattopadhyay D, DeLucas LJ: Stabilization of active site loops in NH3-dependent NAD+synthetase from Bacillus Subtilis. Acta Cryst D Biol Crystallography 57:806-812, 2001.

34. Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT (P4) : Efficient oncolysis by a replicating adenovirus in vivo is critically dependent on tumor expression of primary adenovirus receptors. Cancer Res 61:813-817, 2001.

35. Eltoum I, Fredenburgh J, Grizzle WE (CC) : Advanced concepts in fixation: Effects of fixation on immunohistochemistry, reversibility of fixation and recovery of proteins, nucleic acid, and other molecules from fixed and processed tissues, developmental methods of fixation. J Histotechnol 24:2001.

36. Eltoum I, Fredenburgh J, Myers RB, Grizzle WE (CC) : Introduction to the theory and practice of fixation of tissues. J Histotechnol 24:173-190, 2001.

37. Fabian CJ, Kimler BF (PP) : Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention. Ann NY Acad Sci 952:44-59, 2001.

38. Fabian CJ, Kimler BF (PP) : Breast cancer risk prediction: Should nipple aspiration fluid cytology be incorporated into clinical practice? J Natl Cancer Inst 93:1762-1763, 2001.

39. Fabian CJ, Kimler BF (PP) : Chemoprevention for high-risk women: Tamoxifen and beyond. Breast J 7:311-320, 2001.

40. Frost AR (CC, P2, P3) , Eltoum IE, Siegal GP (CB) : Laser capture microdissection. In: Protocols in Molecular Biology. John Wiley & Sons, Inc., pp. 25A.1.1-25A.1.24, 2001.

41. Grizzle WE (CC) , Fredenburgh J: Avoiding biohazards in medical, veterinary and research laboratories. Biotechnic & Histochemistry 76:183-206, 2001.

42. Grizzle WE (CC) , Stockard CR, Billings PE : The effects of tissue processing variables other than fixation on histochemical staining and immunohistochemical detection of antigens. J Histotechnol 24:213-219, 2001.

43. Han X, Stewart JE Jr, Bellis SL (P3) , Benveniste EN, Ding Q, Tachibana K, Grammer JR, Gladson CL: TGF-beta-1 up-regulates paxillin protein expression in malignant astrocytoma cells: Requirement for a fibronectin substrate. Oncogene 20:7976-7986, 2001.

44. Haviv YS, Blackwell JL, Li H, Wang M, Lei X, Curiel DT (P4) : Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus. Cancer Res 61:8361-8365, 2001.

45. Hemminki A (CD) , Belousova N, Zinn KR (CD) , Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ (P5) , Siegal GP (CB) , Barnes MN, Gomez-Navarro J, Curiel DT (P4) , Alvarez RD: An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol Ther 4:223-231, 2001.

46. Hemminki A (CD) , Dmitriev I (CD) , Liu B, Desmond RA, Alemany R, Curiel DT (P4) : Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule. Cancer Res 61:6377-6381, 2001.

47. Huang YZ, Wang Q, Xiong WC, Mei L (PP) : Erbin is a protein concentrated at postsynaptic membranes that regulates surface expression of ErbB2. J Biol Chem 276:19318-19326, 2001.

48. Ichikawa K, Liu W, Wang Z, Liu D, Koopman WJ, Kimberly RP, Zhou T (P5) : Tumoricidal activity of a novel anti-human DR5 monoclonal antibody. Nature Med 7:954-960, 2001.

49. Johanning GL, Cope M, Wilborn T, Grubbs CJ (P1) , Lubet RA: Effect of high retinoid doses on RAR-beta mRNA expression in female B6D2F1 mice. Anticancer Res 21:1691-1695, 2001.

50. Jones WT, Stockard CR, Grizzle WE (CC) : Effects of time and temperature during attachment of sections to microscope slides on immunohistochemical detection of antigens. Biotechnic & Histochemistry 76:55-58, 2001.

51. Krasnykh VN (PP) , Belousova N, Korokhov N, Mikheeva G, Curiel DT (P4) : Genetic targeting of adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol 75:4176-4183, 2001.

52. Lecureur V, Thottassery JV (PP) , Zambetti GP, Sun D, Schuetz EG, Schuetz JD: Mdr1b facilitates p53-mediated cell death and p53 is required for Mdr1b upregulation in vivo. Oncogene 20:303-313, 2001.

53. Lee YC, Jackson PL, Jablonsky MJ, Muccio DD (P1) , Pfister RR, Haddox JL, Sommers CI, Anantharamaiah GM, Chaddha M: NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Biopolymers 58:548-561, 2001.

54. Mahasreshti PJ, Navarro JG, Kataram M, Wang MH, Carey DE, Siegal GP (CB) , Barnes MN, Nettelbeck DM, Alvarez RD, Hemminki A (CD) , Curiel DT (P4) : Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. Clin Cancer Res 7:2057-2066, 2001.

55. Meredith RF (P6) , Alvarez RD , Partridge EE, Khazaeli MB (P6) , Lin C-Y, Macey DJ, Austin JM Jr, Kilgore LC, Grizzle WE (CC) , Schlom J, LoBuglio AF (P2) : Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study. Cancer Biotherapy & Radiopharmaceuticals 16:305-315, 2001.

56. Morrow M, Krontiras H (P3, PP, CD) : Who should not receive chemotherapy? Data from American databases and trials. J Natl Cancer Inst (Monographs) 30:109-113, 2001.

57. Myers RB, Oelschlager DK, Weiss HL, Frost AR (CC, P2, P3) , Grizzle WE (CC) : Fatty acid synthase: An early molecular marker of progression of prostatic adenocarcinoma to androgen independence. J Urol 165:1027-1032, 2001.

58. Nantais-Smith LM, Covington CY, Nordstrom-Klee BA, Grubbs CJ (P1) , Eto I, Lawson DM, Pieper BA, Northouse LL: Differences in plasma and nipple aspirate carotenoid by lactation status. Nurs Res 50:172-177, 2001.

59. Pereboev A, Pereboev L, Curiel DT (P4) : Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation. J Virol 75:7107-7113, 2001.

60. Ponder MC, Long JA, Williams LM, Hamilton TP, Muccio DD (P1) : Structural studies on conformationally defined 6-s-trans UAB retinoids. Theoretical Chem 549:39-45, 2001.

61. Ponnazhagan S, Curiel DT (P4) , Shaw DR (P5) , Alvarez RD, Siegal GP (CB) : Adeno-associated virus for cancer gene therapy. Cancer Res 61:6313-6321, 2001.

62. Ponnazhagan S, Mahendra G, Curiel DT (P4) , Shaw DR (P5) : Adeno-associated virus-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy. J Virol 75:9493-9501, 2001.

63. Poole JC, Andrews LG, Tollefsbol TO (PP) : Activity, function and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269:1-12, 2001.

64. Posey JA III, Khazaeli MB (P6) , DelGrosso A, Saleh MN, Lin CY, Huse W, LoBuglio AF (P2) : A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti alpha-v-beta-3) antibody in patients with metastatic cancer. Cancer Biotherapy & Radiopharmaceuticals 16:125-132, 2001.

65. Ren XR, Du QS, Huang YZ, Ao SZ, Mei L (PP) , Xiong WC: PSGAP, a novel PH and SH3 domain containing rhoGAP protein, interacts with PYK2 and FAK. J Cell Biol 152:971-984, 2001.

66. Reynolds PN, Holmes MD, Adachi Y, Kaliberova L, Curiel DT (P4) : A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors. Gene Therapy 8:1271-1275, 2001.

67. Reynolds PN, Nicklin SA, Kaliberova L, Boatman GB, Grizzle WE (CC) , Balyasnikova I, Baker AH, Danilov SM, Curiel DT (P4) : Combined transduction and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol 19:838-842, 2001.

68. Rodriguez-Burford C (CC) , Barnes MN, Berry W, Partridge EE, Grizzle WE (CC) : Immunohistochemical expression of molecular markers in an avian model: A potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81:373-379, 2001.

69. Rodriguez-Burford C (CC) , Lubet RA, Steele VE, Eto I, Bandy M, Juliana MM, Weiss HL, Grizzle WE (CC) , Kelloff GJ, Grubbs CJ (P1) : Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention. Oncol Rep 8:373-379, 2001.

70. Sidawy MK, Tabbara SO, Bryan JA, Poprocky LA, Frost AR (CC, P2, P3) : The spectrum of cytologic features in nonproliferative breast lesions. Cancer Cytopath 93:140-145, 2001.

71. Suzuki K, Fueyo J, Krasnykh VN (PP) , Reynolds PN, Curiel DT (P4) , Alemany R: A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clin Cancer Res 7:120-126, 2001.

72. Thummel KE, Brimer C, Yasuda K, Thottassery JV (PP) , Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E: Transcriptional control of intestinal CYP3A4 by 1-alpha,25-dihydroxy vitamin D3. Mol Pharmacol 60:1399-1406, 2001.

73. Tollefsbol TO (PP) , Andrews LG: Mechanisms for telomerase gene control in aging cells and tumorigenesis. Med Hypotheses 56:630-637, 2001.

74. Urban DA, Irwin W, Kirk M, Markiewicz MA, Myers R, Smith M, Weiss HL, Grizzle WE (CC) , Barnes S: The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urology 165:294-300, 2001.

75. Wang Y, Hu L, Yao R, Wang M, Crist KA, Grubbs CJ (P1) , Johanning GL, Lubet RA: Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor. Oncogene 20:7710-7721, 2001.

76. Wang-Johanning F, Frost AR (CC, P2, P3) , Johanning GL, Khazaeli MB (P6) , LoBuglio AF (P2) , Shaw DR (P5) , Strong TV (PP) : Expression of human endogenous retrovirus K envelope transcripts in human breast cancer. Clin Cancer Res 7:1553-1560, 2001.

77. Weiss HL, Urban DA, Grizzle WE (CC) , Cronin KA, Freedman LS, Kelloff GJ, Lieberman R: Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer. Urology 54 (Suppl 1):220-223, 2001.

78. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, Tang H, Wen L, Brady-Kalnay SM, Mei L (PP) , Wu JY, Xiong WC, Rao Y: Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 107:209-221, 2001.

79. Zhang H-G, Wang YM, Xie JF, Liang X, Hsu H-C, Zhang X, Douglas JT, Curiel DT (P4) , Mountz JD: Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus. Gene Therapy 8:704-712, 2001.

80. Zinn KR (CD) , Chaudhuri TR, Buchsbaum DJ (P5) , Mountz JM, Rogers BE: Detection and measurement of in vitro gene transfer by gamma camera imaging. Gene Therapy 8:291-299, 2001.

81. Zinn KR (CD) , Chaudhuri TR, Buchsbaum DJ (P5) , Mountz JM, Rogers BE: Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging. Nucl Med Biol 28:135-144, 2001.